Effects of Extending the Time Window of Thrombolysis to 4.5 Hours
- 1 September 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 42 (9), 2492-2497
- https://doi.org/10.1161/strokeaha.111.618587
Abstract
The European Cooperative Acute Stroke Study (ECASS) III trial and Safe Implementation of Thrombolysis in Stroke–International Stroke Thrombolysis Register (SITS-ISTR) data were published in 2008. Riks-Stroke, the Swedish Stroke Register, was used to explore how thrombolysis in the 3- to 4.5-hour window has been spread in different hospitals and patient groups and what effects this has had on treatment within 3 hours. All 76 hospitals in Sweden admitting patients with acute stroke participate in Riks-Stroke. During the study period, January 2003 to June 2010, 92 150 18- to 80-year-old patients were hospitalized for acute ischemic stroke. After the publication of the ECASS III results in the third quarter of 2008, thrombolysis in the 3- to 4.5-hour window increased from 0.5% before publication to 2.1% in 2010. Thrombolysis in the 3- to 4.5-hour window spread somewhat faster in men than women ( P =0.04) but at a similar rate in different age groups. The use of thrombolysis within 3 hours after onset of symptoms increased successively from 0.9% in 2003 to 6.6% in late 2008 and then it stabilized at 6%. The median time from arrival to the hospital to start of treatment remained unchanged at 66 to 69 minutes before and after 2008 ( P =0.06). Since the end of 2008, there has been a rapid nationwide dissemination of thrombolysis in the 3- to 4.5-hour window, whereas rates in the <3-hour window have leveled off. The extended time window has not affected door-to-needle time.This publication has 17 references indexed in Scilit:
- Outcome by Stroke Etiology in Patients Receiving Thrombolytic TreatmentStroke, 2011
- Stroke Thrombolysis: Having More Time Translates Into Delayed TherapyStroke, 2010
- Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTRThe Lancet Neurology, 2010
- Dissemination of Thrombolysis for Acute Ischemic Stroke Across a NationStroke, 2010
- Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trialsThe Lancet, 2010
- Should more patients with acute ischaemic stroke receive thrombolytic treatment?BMJ, 2009
- Efficacy and Safety of Tissue Plasminogen Activator 3 to 4.5 Hours After Acute Ischemic StrokeStroke, 2009
- Thrombolysis with alteplase 3-4 center dot 5 h after acute ischaemic stroke (SITS-ISTR): an observational studyLancet, 2008
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic StrokeThe New England Journal of Medicine, 2008
- Permutation tests for joinpoint regression with applications to cancer ratesStatistics in Medicine, 2000